Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Paranasal Sinus Neoplasms 1Papillomavirus Infections 1Neoplasms 1Nasopharyngeal Carcinoma 1HIV Infections 1Cervical Cancer Screening 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Human Papillomavirus DNA Tests 6Colposcopy 6Educational Status 5Specimen Handling 4Early Intervention, Educational 4Vaginal Smears 3Surveys and Questionnaires 3Patient Navigation 3Methods 3epigallocatechin gallate 2Vitamin B 12 2Transurethral Resection of Prostate 2Standard of Care 2Practice Guidelines as Topic 2Motivational Interviewing 2Mass Screening 2Electrocoagulation 2Watchful Waiting 1Triage 1Telemedicine 1Standing Orders 1Referral and Consultation 1Radiotherapy, Intensity-Modulated 1Pregnancy Tests 1Papanicolaou Test 1Nimorazole 1Mindfulness-Based Stress Reduction 1Lacteol 1Interviews as Topic 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Papillomavirus Infections × Coal Tar × Clear all
NCT07225530 2026-02-25

(iSTAR)

Columbia University

Phase NA Recruiting
600 enrolled
Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡